Filing Overview
Alignment Healthcare, Inc. filed a Form 8-K on January 10, 2022 under Item 7.01, Regulation FD Disclosure. Management planned investor and analyst meetings from January 10–13, 2022 and provided preliminary updates on fourth-quarter 2021 inpatient utilization and 2022 Annual Enrollment Period performance.
Key Operating and Financial Metrics
- Fourth-quarter 2021 inpatient utilization: Estimated at approximately 155 admissions per thousand, about 5% better than management’s assumption underlying its November 4, 2021 fourth-quarter earnings guidance.
- January 1, 2022 Health Plan Members: Approximately 92,700 members in HMO and PPO contracts, representing approximately 16% year-over-year growth compared with January 1, 2021.
- Direct Contracting Entity members: Approximately 5,400, excluded from the 92,700 Health Plan Member estimate.
- Revenue, profit, cash flow, margins, debt, and liquidity: The filing provides no new GAAP or other financial information because the company was still closing its 2021 books.
Material Changes and Outlook
- The preliminary inpatient utilization estimate was approximately 5% better than the assumption used in prior fourth-quarter earnings guidance.
- The company completed the 2022 Annual Enrollment Period and estimated 16% year-over-year Health Plan Member growth as of January 1, 2022.
- The membership estimate was based on internal AEP sales and disenrollment data and could change over the following 30 to 60 days as retroactive enrollment and disenrollment information was reported by the Centers for Medicare and Medicaid Services.
- The company stated that it would not provide forward-looking 2022 Health Plan Membership growth guidance until issuing holistic 2022 guidance.
Risks, Contingencies, and Unusual Items
COVID-19’s impact remained evolving and could affect inpatient utilization, medical expenses, operations, and financial results. The filing’s forward-looking statements are subject to risks including member acquisition and market expansion, maintaining Medicare plan Five Star ratings, government-contractor requirements, legal and regulatory changes, market acceptance of the company’s technology and services, litigation or security incidents, personnel shortages and labor costs, and COVID-19 effects.
The company cautioned that the preliminary membership estimate may be revised and that actual results may differ materially from forward-looking statements. It undertook no duty to update the information except as required by law.
Investor Verification Items
- Verify final fourth-quarter 2021 inpatient utilization and resulting medical expense performance.
- Verify final 2021 revenue, profitability, cash flow, margins, debt, liquidity, and year-end financial statements when reported.
- Confirm final January 1, 2022 membership after CMS retroactive enrollment and disenrollment adjustments.
- Review the company’s comprehensive 2022 guidance when issued, including membership, revenue, medical costs, and profitability expectations.
- Assess the continuing effects of COVID-19, regulatory requirements, Five Star ratings, labor costs, and other risks identified in the company’s SEC filings.